|By Business Wire||
|August 7, 2014 06:30 AM EDT||
Foundation Medicine, Inc. (NASDAQ:FMI) today announced the appointment of life sciences executive Lisa Ricciardi to the newly created position of senior vice president, corporate and business development. In this role, Ms. Ricciardi will be responsible for overseeing the company’s biopharmaceutical partnerships as well as corporate and business development activities across the company.
“Lisa brings a tremendous level of experience and expertise in areas that will help Foundation Medicine further its vision to transform cancer care,” commented Steven J. Kafka, Ph.D., chief operating officer of Foundation Medicine. “Her leadership will help us to accelerate the advancement of our new product pipelines for both clinical and technology products, and to explore new collaborative opportunities that we expect will increase our impact for patients and other key stakeholders, while also driving shareholder value.”
Prior to joining Foundation Medicine, Ms. Ricciardi held numerous senior business development and marketing roles in pharmaceuticals, healthcare services, and finance. Ms. Ricciardi spent several years at Pfizer culminating in the role of senior vice president, licensing and development, where she led more than two dozen complex, multinational, multi-year deals across a host of disease areas, including oncology. Ms. Ricciardi was also a venture partner for Essex Woodlands Health Ventures, and served as senior vice president of U.S. and international business development in the healthcare services sector at Medco Health Solutions. Most recently, Ms. Ricciardi served as a consultant to the specialty pharmacy division of DaVita, a full-service pharmacy specializing in renal care.
Ms. Ricciardi is currently a member of the Board of Directors of United Drug Group, PLC in Dublin, Ireland, and a director with Chimerix in Durham, North Carolina. Ms. Ricciardi earned an MBA from the University of Chicago and a bachelor’s degree with honors from Wesleyan University in Middletown, Connecticut.
About Foundation Medicine
Foundation Medicine (NASDAQ: FMI) is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company's clinical assays, FoundationOne for solid tumors and FoundationOne Heme for hematologic malignancies, sarcomas and pediatric cancers, provide a fully informative genomic profile to identify the molecular alterations in a patient's cancer and match them with relevant targeted therapies and clinical trials. Foundation Medicine's molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. For more information, please visit www.FoundationMedicine.com or follow Foundation Medicine on Twitter (@FoundationATCG).
Foundation Medicine® and FoundationOne® are registered trademarks of Foundation Medicine, Inc.
Aug. 31, 2015 02:00 PM EDT Reads: 170
Aug. 31, 2015 01:45 PM EDT Reads: 406
Aug. 31, 2015 01:05 PM EDT
Aug. 31, 2015 12:30 PM EDT Reads: 353
Aug. 31, 2015 12:16 PM EDT
Aug. 31, 2015 12:15 PM EDT
Aug. 31, 2015 12:00 PM EDT Reads: 200
Aug. 31, 2015 12:00 PM EDT
Aug. 31, 2015 11:30 AM EDT Reads: 887
Aug. 31, 2015 11:15 AM EDT Reads: 226
Aug. 31, 2015 11:00 AM EDT Reads: 160
SYS-CON Events announced today the Containers & Microservices Bootcamp, being held November 3-4, 2015, in conjunction with 17th Cloud Expo, @ThingsExpo, and @DevOpsSummit at the Santa Clara Convention Center in Santa Clara, CA. This is your chance to get started with the latest technology in the industry. Combined with real-world scenarios and use cases, the Containers and Microservices Bootcamp, led by Janakiram MSV, a Microsoft Regional Director, will include presentations as well as hands-on...
Aug. 31, 2015 10:45 AM EDT Reads: 282
Through WebRTC, audio and video communications are being embedded more easily than ever into applications, helping carriers, enterprises and independent software vendors deliver greater functionality to their end users. With today’s business world increasingly focused on outcomes, users’ growing calls for ease of use, and businesses craving smarter, tighter integration, what’s the next step in delivering a richer, more immersive experience? That richer, more fully integrated experience comes ab...
Aug. 31, 2015 10:30 AM EDT Reads: 642
Cloud and datacenter migration innovator AppZero has joined the Microsoft Enterprise Cloud Alliance Program. AppZero is a fast, flexible way to move Windows Server applications from any source machine – physical or virtual – to any destination server, in any cloud or datacenter, using its patented container technology. AppZero’s container is also called a Virtual Application Appliance (VAA). To facilitate Microsoft Azure onboarding, AppZero has two purpose-built offerings: AppZero SP for Azure,...
Aug. 31, 2015 10:15 AM EDT Reads: 182
SYS-CON Events announced today that Pythian, a global IT services company specializing in helping companies leverage disruptive technologies to optimize revenue-generating systems, has been named “Bronze Sponsor” of SYS-CON's 17th Cloud Expo, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Founded in 1997, Pythian is a global IT services company that helps companies compete by adopting disruptive technologies such as cloud, Big Data, advance...
Aug. 31, 2015 10:15 AM EDT Reads: 300